Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.

Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.

This grant supports the advanced training of two aspiring veterinary pathologists who will assist with the analysis of tissue samples collected from dogs enrolled in Morris Animal Foundation's Golden Retriever Lifetime Study.

Researchers will investigate how equine muscle cells regulate calcium movement, and examine its role in equine muscle diseases.

Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.

Researchers will investigate genetic risk factors for equine recurrent uveitis, a common eye condition and leading cause of blindness in horses.

Researchers will investigate how to improve diagnosis and treatment of equine insect bite hypersensitivity, one of the most common allergic skin diseases in horses.

Researchers will investigate a new treatment strategy against antibiotic-resistant foal pneumonia.

Researchers will study biomechanical forces in different horse gaits as well as genetic risk factors associated with the development of osteochondrosis (OC) in Standardbred horses, a breed with high prevalence of OC lesions.

Researchers will search for candidate genes associated with equine metabolic syndrome in five horse breeds – Arabian, Morgan, quarter horse, Tennessee walking horse, and Welsh pony.